2BB score and signals
Verrica Pharmaceuticals Inc.’s current 2BB score is 53 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 62 | High |
| Momentum | 78 | Improving |
| Financial strength | 25 | Weak |
| Quality | 79 | Strong |
| Risk | 62 | High |
Company facts
| CEO | Jayson Rieger |
| Headquarters | West Chester, Pennsylvania, United States |
| Founded | 2013 |
| Employees | 76 |
| 52-week range | $3.28 – $9.82 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-03-08 | — | -0.5035 | — | $7.95M |
| 2026-11-12 | — | -0.5197 | — | $6.81M |
| 2026-08-06 | — | -0.3842 | — | $5.85M |
| 2026-05-12 | -0.41 | -0.3871 | $4.29M | $4.61M |
Related companies
